OrbusNeich Says “Bio-Engineered” Stent May Be Solution To Thrombosis Risk

OrbusNeich hopes to lead a new wave of stent technology with its Genous Bio-engineered R-Stent, which the firm says is safer than existing drug-eluting stents because it has a natural antibody coating instead of a drug-eluting polymer

More from Archive

More from Medtech Insight